In an investigation of the indications for hepatic resection in the treatment of colorectal carcinoma metastases, the records of 859 patients who had undergone this procedure were reviewed. This patient group, from 24 institutions, was found to have a 5-year actuarial survival of 33% and a 5-year actuarial disease-free survival of 21%.
The only factors that might by themselves be considered contraindications to hepatic resection are the presence of positive hepatic nodes, the presence of resectable extrahepatic metastases, or the presence of four or more metastases. Other factors that had a negative effect on long-term survival were margins of resection on the liver metastases less than or equal to 1 cm (S [5-year actuarial survival] 23%), the presence of positive mesenteric nodes in the primary tumor specimen (S 23%), and a disease-free interval of less than 1 year (S 24%). The effect of any one of these factors was not great enough to contraindicate resection. However, combinations of prognostic factors must be considered before resection is recommended. The overall 5-year survival rate for this large series has been very satisfying. Decision making in the future must take into account such factors as numbers of metastases, extrahepatic involvement, and stage of the primary tumor. and when a disease-free interval of less than one year existed between the resection of the primary colorectal tumour and the hepatic resection for metastases (5-year survival 24%).
The analysis of the large number of patients with solitary metastases (509 patients) is of special interest. The 5-year survival was 37% in this group and the disease-free survival 25%. Note also that patients with tumours less than 4 cm fared as well with a wedge resection as when a formal anatomical liver resection was performed. However, patients with solitary metastases larger than 4 cm fared better with an anatomical liver resection. Note that their patients having anatomical resections included less Duke's C patients (51%) and less synchronous metastases (37%) than those patients who underwent a wedge resection (67% Duke's C and 57% synchronous). In my opinion it is important that attempts be made in the future to further analyse this specific group of tumours. When the present material is compared with the Lund series from 19861 it is interesting that both series have 36% multiple tumours. However, solitary lesions were 64% in the present study and only 49% in the Lund material. Our study contained a third group with solitary tumours with multiple small satellite tumours in the surrounding liver. The present study does not indicate where these cases are included in their data. Our study showed that these patients accounted for as many as 15% of the patients and had a great influence on survival with a 0% 3 and 5-year survival. In future studies this subset should be identified and reported separately.
It has been calculated that only some 10% of patients who are suitable for hepatic resection for colorectal metastases are referred to a surgical institution capable of undertaking the procedure because of prejudices based on three common misconceptions. 
